Pitfalls in Membrane Binding Sites Studies in Post-Mortem Human Brain

References

• Olsen R. W., Reisine T. D., Yamamura H. I. Neurotransmitter receptors - Biochemistry and alterations in neuropsychiatric disorders. Life Sci. 1980; 27: 801–808
   PubMed Web of Science ®Google Scholar
• Rinne U. K., Koskinen V., Lonnberg P. Parkinson's disease - Current Progress, Problems and Management, U. K. Rinne, M. Klinger, M. Stamm. Elsevier/North-Holland Press. 1980; 93–107
   Google Scholar
• Whitehouse P. J., Trifiletti R. R., Jones B. E., Folstein S., Price D. L., Snyder S. H., Kuhar M. J. Neurotransmitter receptor alterations in Huntington's disease : autoradiographic and homogenate studies with special reference to benzodiazepine receptor complexes, Ann. Neurol. 1985; 18: 202–210
   Web of Science ®Google Scholar
• Hardy J., Adolfsson R., Alafuzoff I., Bucht G., Marcusson J., Nyberg P., Perdahl E., Wester P., Winblad B. Transmitter deficits in Alzheimer's disease, Neurochem. Int. 1985; 7: 545–563
   Google Scholar
• Ruberg M., Javoy-Agid F., Hirsch E., Scatton B., Lheureux R., Hauw J. J., Duyckaerts C., Gray F., Morel-Maroger A., Rascol A., Serdaru M., Agid Y. Dopaminergic and cholinergic lesions in progressive supranuclear palsy, Ann. Neurol. 1985; 18: 523–529
   Web of Science ®Google Scholar
• Owen F., Cross A. J., Crow T. J., Longden A., Poulter M., Riley G. J. Increased dopamine receptor sensitivity in schizophrenia. Lancet 1978; ii: 223–226
   Google Scholar
• Seeman P., Ulpian C., Bergeron C., Riederer P., Jellinger K., Gabriel E., Reynolds G. P., Tourtellotte W. W. Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 1984; 225: 728–731
   PubMed Web of Science ®Google Scholar
• Meyerson L. R., Wennogle L. P., Abel M. S., Coupet J., Lippa A. S., Rauh C. E., Beer B. Human brain receptor alterations in suicide victims, Pharm. Biochem. Behav. 1982; 17: 159–163
   PubMed Web of Science ®Google Scholar
• Stanley M., Virgilio J., Gershon S. Tritiated imipramine binding sites are decreased in the frontal cortex of suicides. Science 1982; 216: 1337–1339
   PubMed Web of Science ®Google Scholar
• Stanley M., Mann J. J. Increased serotonin 2 binding sites in frontal cortex of suicide victims. Lancet 1983; i: 214–215
   Google Scholar
• Perry E. K., Marshall E. F., Blessed G., Tomlinson B. E., Perry R. H. Decreased imipramine binding in the brains of patients with depressive illness, Br. J. Psychiatr. 1983; 142: 188–192
   PubMed Web of Science ®Google Scholar
• Seeman P., Ulpian C., Wreggett K. A., Wells J. W. Dopamine receptor parameters detected by 3H-spiperone depend on tissue concentration : analysis and examples. J. Neurochem. 1984; 43: 221–235
   PubMed Web of Science ®Google Scholar
• Cash R., Raisman R., Ploska A., Agid Y. High and low affinity 3H-imipramine binding sites in control and parkinsonian patients, European J. Pharmacol. 1985; 117: 71–80
   Web of Science ®Google Scholar
• Perry E. K., Perry R. H. Human brain neurochemistry some post-mortem problems. Life Sci. 1983; 33: 1733–1743
   PubMed Web of Science ®Google Scholar
• Hardy J. A., Dodd P. R. Metabolic and functional studies on post-mortem human brain, Neurochem. Int. 1983; 5: 253–266
   Google Scholar
• Rossor M. Biological markers in mental disorders: post-mortem studies. J. Psychiatr. Res. 1984; 18: 457–465
   PubMed Web of Science ®Google Scholar
• Monfort J. C., Javoy-Agid F., Hauw J. J., Dubois B., Agid Y. Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain 1985; 108: 301–313
   PubMed Web of Science ®Google Scholar
• Cash R., Raisman R., Ruberg M., Agid Y. Adronergic receptors in frontal cortex in human brain, European J. Pharmacol. 1985; 108: 225–232
   Google Scholar
• Greengrass P., Bremner R. Binding characteristics of 3H-prazosin to rat brain alpha-adrenergic receptors, European J. Pharmacol 1979; 55: 323–326
   Web of Science ®Google Scholar
• Perry B. D., U'Prichard D. C. 3H-rauwolscine (alpha-yohimbine): a specific antagonist radioligand for brain alpha-2 adrenergic receptors, European J. Pharmacol. 1981; 76: 461–464
   Web of Science ®Google Scholar
• Alexander R. W., Davis J. N., Lefkowitz R. J. Direct identification and characterization of beta-adrenergic receptors in rat brain. Nature 1975; 258: 437–440
   PubMed Web of Science ®Google Scholar
• Raisman R., Briley M. S., Langer S. Z. High-affinity 3H-imipramine binding in rat cerebral cortex, European J. Pharmacol. 1979; 54: 307–308
   Web of Science ®Google Scholar
• Langer S. Z., Moret C., Raisman R., Dubocovich M. L., Briley M. S. High-affinity 3H-imipramine binding in rat hypothalamus: association with uptake of serotonin but not of epinephrine. Science 1980; 210: 1133–1135
   PubMed Web of Science ®Google Scholar
• Paul S. M., Rehavi M., Rice K. C., Yttah Y., Skolnick P. Does high affinity 3H-imipramine binding label serotonin reuptake sites in brain and platelets?. Life Sci. 1981; 28: 2753–2760
   PubMed Web of Science ®Google Scholar
• Peroutka S. J., Snyder S. H. Two distinct serotonin receptors: regional variations in receptor binding in mammalian brain. Brain Res. 1981; 208: 339–347
   PubMed Web of Science ®Google Scholar
• Kuhar M. J., Pert C. B., Snyder S. H. Regional distribution of opiate receptor binding in monkey and human brain. Nature 1973; 245: 447–450
   PubMed Web of Science ®Google Scholar
• Enna S. J., Bird E. D., Bennett J. P., Bylund D. B., Yamamura H. I., Iversen L. L., Snyder S. H. Huntington's chorea. Changes in neurotransmitter receptors in the brain, New England J. Med. 1976; 294: 1305–1309
   PubMed Web of Science ®Google Scholar
• Braestrup C., Albrechtsen R., Squires R. F. High densities of benzodiazepine receptors in human cortical areas. Nature 1977; 269: 702–704
   PubMed Web of Science ®Google Scholar
• Reisine T. D., Fields J. Z., Yamamura H. I. Neurotransmitter receptor alterations in Parkinson's disease. Life Sci. 1977; 21: 335–344
   PubMed Web of Science ®Google Scholar
• Lloyd K. G., Dreksler S. An analysis of 3H-gamma-aminobutyric acid (GABA) binding in the human brain. Brain Res. 1979; 163: 77–87
   PubMed Web of Science ®Google Scholar
• Weiner N., Martin C., Wesemann W., Riederer P. Effect of post-mortem storage on synaptic 5-HT binding and uptake in mammalian brain. J. Neural Transm. 1979; 46: 253–262
   PubMed Web of Science ®Google Scholar
• Perry E. K. The cholinergic system in old age and Alzheimer's disease. Age and Ageing 1980; 9: 1–8
   PubMed Web of Science ®Google Scholar
• Davies P., Feisullin S. Post-mortem stability of alpha-bungarotoxin binding sites in mouse and human brain. Brain Res. 1981; 216: 449–454
   PubMed Web of Science ®Google Scholar
• Heltzel J. O., Boehme D. H., Vogel W. H. Serotonin binding to different regions of human brain. Brain Res. 1981; 204: 451–454
   PubMed Web of Science ®Google Scholar
• Tran V. T., Snyder S. H., Major L. F., Hawley R. J. GABA receptors are increased in brains of alcoholics, Ann. Neurol. 1981; 9: 289–292
   Web of Science ®Google Scholar
• Severson J. A., Marcusson J., Winblad B., Finch C. E. Age-correlated loss of dopaminergic binding sites in human basal ganglia. J. Neurochem. 1982; 39: 1623–1631
   PubMed Web of Science ®Google Scholar
• Unden A., Meyerson B., Winblad B., Sachs C., Bartfai T. Post-mortem changes in binding to the muscarinic receptor from human cerebral cortex. J. Neurochem. 1983; 41: 102–106
   PubMed Web of Science ®Google Scholar
• Whitehouse P. J., Lynch D., Kuhar M. J. Effects of post-mortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process. J. Neurochem. 1984; 43: 553–559
   PubMed Web of Science ®Google Scholar
• Marcusson J. O., Oreland L., Winblad B. Effect of age on human brain serotonin (S-1) binding sites. J. Neurochem. 1984; 43: 1699–1705
   PubMed Web of Science ®Google Scholar
• Marcusson J. O., Morgan D. G., Winblad B, Finch C. E. Serotonin 2 binding sites in human frontal cortex and hippocampus. Selective loss of S-2A sites with age, Brain Res. 1984; 311: 51–56
   Google Scholar
• Ruberg M., Bokobza B., Javoy-Agid F., Montfort J. C., Agid Y. 3H-spiperone binding in the nigro-striatal system in human brain, European J. Pharmacol. 1984; 99: 159–165
   Google Scholar
• Severson J. A., Marcusson J. O., Osterburg H. H., Finch C. E., Winblad B. Elevated density of 3H imipramine binding in aged human brain. J. Neurochem. 1985; 45: 1382–1389
   PubMed Web of Science ®Google Scholar
• Roth G. S., Hess G. D. Changes in the mechanisms of hormone and neurotransmitter action during aging : current status of the role of receptor and post receptor alterations. 1982; 175, 194, A review, Mechanisms of Ageing and Development 20
   Google Scholar
• White P., Hiley C. R., Goodhart M. J., Carrasco L. H., Keet J. P., Williams I. E.I., Bowen D. M. Neocortical cholinergic neurons in elderly people. Lancet 1977; i: 668–671
   Google Scholar
• Davies P., Verth A. H. Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's type dementia brains. Brain Res. 1978; 138: 385–392
   Web of Science ®Google Scholar
• Shih J. C., Young H. The alteration of serotonin binding sites in aged human brain. Life Sci. 1978; 23: 1441–1448
   PubMed Web of Science ®Google Scholar
• Maggi A., Schmidt M. J., Ghetti B., Enna S. J. Effect of aging on neurotransmitter receptor binding in rat and human brain. Life Sci. 1979; 24: 367–374
   PubMed Web of Science ®Google Scholar
• Nordberg A., Winblad B. Cholinergic receptors in human hippocampus - regional distribution and variance with age. Life Sci. 1981; 29: 1937–1944
   PubMed Web of Science ®Google Scholar
• Allen S. J., Benton J. S., Goodhart M. J., Haan E. A., Sims N. R., Smith C. C.T., Spillane J. A., Bowen D. M., Davison A. N. Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain. J. Neurochem. 1983; 41: 256–265
   PubMed Web of Science ®Google Scholar
• Wong D. F., Wagner H. N., Dannals R. F., Links J. M., Frost J. J., Ravert H. T., Wilson A. A., Rosenbaum A. E., Gjedde A., Douglass K. H., Petronis J. D., Folstein M. F., Toung J. K.T., Burns H. D., Kuhar M. J. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 1984; 226: 1393–1396
   PubMed Web of Science ®Google Scholar
• Severson J. A. Neurotransmitter receptors and aging. J. Am. Ger. Soc. 1984; 32: 24–27
   PubMed Web of Science ®Google Scholar
• Bowen D. M., Smith C. B., White P., Davison A. N. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 1976; 99: 459–496
   PubMed Web of Science ®Google Scholar
• Perry E. K., Perry R. H., Tomlinson B. E. The influence of agonal status on some neurochemical activities of post-mortem human brain tissue, Neurosci. Lett. 1982; 29: 303–307
   Google Scholar
• Bucht G., Adolfsson R., Gottfries C. G., Roos B. E., Winblad B. Distribution of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J. Neural Transm. 1981; 51: 185–203
   PubMed Web of Science ®Google Scholar
• Wester P., Bateman D. E., Dodd P. R., Edwardson J. A., Hardy J. A., Kidd A. M., Perry R. H., Singh G. B. Agonal status affects the metabolic activity of nerve endings isolated from post-mortem human brain. Neurochemical Pathol. 1985; 3: 169–180
   PubMedGoogle Scholar
• Peroutka S. J., Snyder S. H. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency, Am. J. Psychiat. 1980; 137: 1518–1522
   PubMed Web of Science ®Google Scholar
• Richelson E., Nelson A. Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro, European J. Pharmacol. 1984; 103: 197–204
   Web of Science ®Google Scholar
• Rommelspacher H., Strauss S. Neuroleptics and beta-carbolines displace 3H-imipramine from its binding sites in human and rat tissues. J. Neural Transm. 1985; 61: 55–64
   PubMed Web of Science ®Google Scholar
• Tsukamoto T., Asakura M., Hirata N., Imakufu J., Matsui H., Hasegawa K. Interaction of neuroleptics and antidepressants with rat brain alpha-2 receptors : a possible relationship between alpha-2 receptor antagonism and antidepressant action, Biol. Psychiat. 1984; 19: 1283–1291
   Google Scholar
• Helmeste D. M., Tang S. W. Unusual acute effects of antidepressants and neuroleptics on S2 serotoninergic receptors. Life Sci. 1983; 33: 2527–2533
   PubMed Web of Science ®Google Scholar
• Andree T. H., Mikuni M., Tong C. Y., Koenig J. I., Meltzer H. Y. Differential Effect of subchronic treatment with various neuroleptic agents on serotonin-2 receptors in rat cerebral cortex. J. Neurochem. 1986; 46: 191–197
   PubMed Web of Science ®Google Scholar
• Seeman P. Dopamine receptors in post-mortem schizophrenic brains. Lancet 1981; i: 1103
   Google Scholar
• Hamburg M., Tallman J. F. Chronic morphine administration increases the apparent number of alpha 2 adrenergic receptors in rat brain. Nature 1981; 291: 493–495
   PubMed Web of Science ®Google Scholar
• Plishka R. J., Neale J. H. Morphine treatment increases clonidine binding in brain cell cultures, Neurosci. Lett. 1984; 51: 281–286
   Google Scholar